Position in BMY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$984,149
-$77,771 QoQ
Shares Held
17,080
-2.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#1,173
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MEANS INVESTMENT CO., INC. holds $25,645,348 across 8 Drug Manufacturers - General names. BMY ranks #6 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
28,110 | $7,139,096 | |
| 2 | ABBV |
AbbVie Inc.
|
22,908 | $5,764,569 | |
| 3 | LLY |
ELI LILLY & Co
|
4,726 | $5,668,506 | |
| 4 | MRK |
Merck & Co., Inc.
|
27,981 | $3,595,558 | |
| 5 | NVS |
Novartis AG
|
6,330 | $992,037 | |
| 6 | BMY |
Bristol Myers Squibb Co
This page
|
17,080 | $984,149 | |
| 7 | AMGN |
Amgen Inc
|
2,444 | $885,021 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
4,879 | $616,412 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $984,149 | 17,080 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,061,920 | 17,509 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $973,293 | 18,044 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $972,085 | 21,554 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,045,968 | 22,596 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $1,543,351 | 25,305 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $1,688,033 | 29,845 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $1,508,169 | 29,149 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $1,351,635 | 32,546 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $1,837,149 | 33,877 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $2,098,271 | 40,894 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $2,950,347 | 50,833 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $3,534,388 | 55,268 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $3,765,612 | 54,330 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $3,910,338 | 54,348 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $3,890,044 | 54,720 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $4,193,651 | 54,463 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $3,943,108 | 53,993 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $3,368,396 | 54,024 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,178,671 | 53,721 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,407,820 | 51,000 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $3,238,253 | 51,295 | Shares | Sole | 2021-04-05 | |
| 2020-12-31 | $3,382,557 | 54,531 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $3,283,091 | 54,455 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $3,254,815 | 55,354 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $3,063,024 | 54,952 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||